Skip to main content

Is Hypomagnesemia a Marker of Efficacy of Cetuximab in Locoregionally Advanced and Metastatic Head and Neck Cancer?

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
Is Hypomagnesemia a Marker of Efficacy of Cetuximab in Locoregionally Advanced and Metastatic Head and Neck Cancer?

User login

Username

Password

Reset your password

Type	Lead	score